Faster infusions for kids with IBD: shorter wait, same safety?

NCT ID NCT06839820

First seen Apr 28, 2026 · Last updated Jun 10, 2026 · Updated 5 times

Summary

This study looks at whether giving infliximab over 30 minutes is just as safe as the standard 60-minute infusion for children with inflammatory bowel disease (IBD). About 60 children aged 1-17 who have already had at least 5 infliximab infusions will receive 8 infusions, alternating between 30-minute and 60-minute rates. The goal is to see if faster infusions cause the same number of reactions and improve satisfaction for patients and families.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENT SATISFACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Akershus University Hospital

    Lørenskog, 1478, Norway

Conditions

Explore the condition pages connected to this study.